Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses. (2011)

First Author: Pink J
Attributed to:  North West HTMR funded by MRC

Abstract

No abstract provided

Bibliographic Information

PubMed Identifier: 22042753

Publication URI: http://europepmc.org/abstract/MED/22042753

Type: Journal Article/Review

Volume: 343

Parent Publication: BMJ (Clinical research ed.)

ISSN: 0959-8138